Merit Financial Group »

Akebia Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $16k 14k 1.14

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Apple Put Option (AAPL)
Gmo Etf Trust Us Quality Etf (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Isha In Ctry Etf (CORO)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Merit Financial Group

Top funds holding Akebia Therapeutics

BlackRock
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Goldman Sachs Group
Citigroup
Bank of America Corporation
Qube Research & Technologies
Millennium Management
Vanguard Portfolio Management
Charles Schwab Investment Management
Nantahala Capital Management
Northern Trust
Renaissance Technologies
AQR Capital Management

View all funds holding Akebia Therapeutics